average weight loss glp-1 drugs costs rise, but there are ways to save on weight-loss Upgrading from Overweight: The Effects

Yan W, Pang M, Yu Y, et al

Weight loss in patients receiving GLP-1 receptor agonists is thought to occur as a result of slowed gastric emptying and increased satiety

For current practice, the most defensible use of GLP-1RAs is as a time-bounded metabolic optimization strategy in women with meaningful obesity/insulin-resistance burden, with reproductive endpoints interpreted as potential downstream gains rather than guaranteed direct effects (111, 112, 124)

The narrative review on supplements during GLP-1 therapy A narrative review published in a peer-reviewed journal specifically examined dietary supplement considerations during GLP-1 receptor agonist treatment

All UK pharmacies and prescribers must be properly regulated (GPhC, GMC, CQC registered)

[DOI] [PMC free article] [PubMed] [Google Scholar] 88